UNSPSC 85504629: Restriction of right axillary artery with intraluminal device, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to restriction of right axillary artery with intraluminal device, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 03V53DZ

UNSPSC 85504629 Restriction of right axillary artery with intraluminal device, percutaneous approach is a Commodity code that shows no relevant recent state and local procurement activity. The six most recent opportunities posted under or near this code—independent medical evaluations for public safety pension disability determinations, surgical benefit carve-out programs, occupational medical surveillance, juvenile detention healthcare services, pharmacy benefit management, and temporary health professional staffing—are administrative health services, employee benefits programs, and occupational health screening unrelated to vascular interventional procedures or the specific clinical procedure the code describes. The code nominally addresses a percutaneous endovascular restriction of the right axillary artery, a specialized vascular surgery technique, yet the sourced solicitations span organizational health benefits administration, medical record review, occupational compliance screening, and temporary staffing placement—none of which involve interventional cardiology or vascular surgery procurement.

State and local health systems, counties, and municipalities do purchase clinical services and supplies, but this code does not reflect that activity in the recent record. The mismatch suggests either that state and local procurement offices rarely use this specific procedure code when acquiring vascular services, or that interventional vascular procedures are procured through different UNSPSC classifications. A business development professional evaluating this code should verify with target agencies whether vascular intervention services are classified elsewhere in their procurement systems and whether direct relationships with health system interventional departments or cardiology networks offer a more productive entry point than monitoring this code for future solicitations.